Join to view full profile
10789 Bradford RdSte 204Littleton, CO 80127
Phone+1 303-951-3765
Fax+1 303-951-3764
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Mauldin, MD is a board certified psychiatrist in Littleton, Colorado. He is currently licensed to practice medicine in Colorado, Wyoming, and Florida.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Psychiatry, 1995 - 1999
Texas Tech University Health Sciences Center School of MedicineClass of 1995
Certifications & Licensure
AZ State Medical License 2025 - 2028
FL State Medical License 2026 - 2028
IA State Medical License 2025 - 2028
MT State Medical License 2024 - 2028
WA State Medical License 2025 - 2028
CO State Medical License 2001 - 2027
WY State Medical License 2026 - 2027
American Board of Psychiatry and Neurology Psychiatry- Join now to see all
Publications & Presentations
PubMed
- 19 citationsEffects of repeated-dose isradipine on the abuse liability of cocaine.John D. Roache, Bankole A. Johnson, Nassima Ait-Daoud, James B. Mauldin, Joe E. Thornton
Experimental and Clinical Psychopharmacology. 2005-11-01 - 9 citationsAcute intravenous low- and high-dose cocaine reduces quantitative global and regional cerebral blood flow in recently abstinent subjects with cocaine use disorder.Bankole A. Johnson, Michael A. Dawes, John D. Roache, Lynda T. Wells, Nassima Ait-Daoud
Journal of Cerebral Blood Flow and Metabolism. 2005-07-01 - 18 citationsEffects of isradipine on cocaine-induced subjective mood.Bankole A. Johnson, John D. Roache, Nassima Ait-Daoud, Lynda T. Wells, James B. Mauldin
Journal of Clinical Psychopharmacology. 2004-04-01
